FDA Person
FDAChristopher M. Jenner
View detailed information about Christopher M. Jenner, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of Christopher M. Jenner, including their role, qualifications, and regulatory activities.
Recent Records (30)
Page 1 of 2EIR - Nexgen Pharma Inc
EIR
483 - Foothills Professional Pharmacy, LTD
483
483 - Customcoatial Compounding, LLC
483
483 - Central Admixture Pharmacy Services, Inc.
483
483 - First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
483
483 - First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
483
483 - Virginia Mason Medical Center
483
WARNING_LETTER - HTO Nevada, Inc. dba Kirkman
WARNING_LETTER
483 - SALUS MEDICAL LLC
483
483 - kdc/one Chatsworth, Inc.
483
483 - First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
483
483 - TOLMAR, Inc.
483
483 - Precision Science Inc
483
483 - Medical Purchasing Solutions, LLC
483
483 - Customcoatial Compounding, LLC
483
483 - Island Kinetics, Inc. d.b.a. CoValence Laboratories
483
483 - Airgas USA, LLC - Phoenix University Street
483
483 - Specialty Formulations & Manufacturing, LLC
483
483 - Mayo Clinic PET Radiochemistry Facility
483
483 - West Pharmaceutical Services AZ, Inc
483
Showing 1-20 of 30 records
Person Information
Name
Christopher M. Jenner
Role
Regulatory Personnel
ID: d2fbd516-71aa-4263-8ffb-57b8149d6b64
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox